Health Care & Life Sciences » Pharmaceuticals | Chongqing Taiji Industry

Chongqing Taiji Industry | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
44,035.80
264,004.40
230,177.30
852,049.60
95,432.50
62,047.70
Depreciation, Depletion & Amortization
165,174.80
157,462.40
174,043.70
200,445.90
193,698.00
212,119
Other Funds
172,722.00
1,368,219.60
297,159.40
742,390.40
269,877.30
359,741.10
Funds from Operations
354,896.30
217,377.20
155,456.80
122,043.60
505,493.40
582,092.40
Changes in Working Capital
492,607.70
491,427.00
93,735.70
18,807.10
641,823.40
472,106.50
Net Operating Cash Flow
137,711.50
274,049.70
61,721.10
103,236.60
136,330.00
109,985.90
Capital Expenditures
366,196.40
252,352.70
334,443.50
325,031.70
481,352.50
Sale of Fixed Assets & Businesses
398,716.50
420,056.90
720,560.40
390,122.30
7,730.50
Purchase/Sale of Investments
-
75,166.20
192,488.00
116,570.10
9,435.10
Net Investing Cash Flow
77,097.50
157,700.20
583,140.60
357,550.60
472,142.10
Cash Dividends Paid - Total
-
-
-
-
127,946.50
Issuance/Reduction of Debt, Net
114,106.10
978,489.50
144,696.70
276,142.60
901,035.90
Net Financing Cash Flow
58,616.00
389,730.10
441,856.10
466,247.80
503,212.00
Net Change in Cash
273,409.20
273,381.50
79,565.00
211,822.50
105,245.20
Free Cash Flow
503,907.80
526,402.40
396,164.70
428,268.30
617,682.50
Deferred Taxes & Investment Tax Credit
2,951.40
16,891.20
28,270.60
7,354.50
20,229.00
51,815.40
Net Assets from Acquisitions
13,072.70
-
-
3,000.00
1,835.10
Other Sources
-
23,789.80
50,000.00
178,890.00
12,750.00
Exchange Rate Effect
15.80
1.00
1.70
111.30
14.90
Other Uses
96,545.00
108,960.00
45,464.20
-
-

About Chongqing Taiji Industry

View Profile
Address
38 Huanglong Road
Chongqing Chongqing 401147
China
Employees -
Website http://www.taiji.com
Updated 07/08/2019
Chongqing Taiji Industry (Group) Co., Ltd. engages in the processing, production and distribution of Chinese patent medicines and health care products. It offers capsules, syrup, oral liquid, lyophilized series, tablets, infusion series and injections. The company was founded on November 18, 1993 and is headquartered in Chongqing, China.